Healthcare / Medical Care FacilitiesSES
$0.25
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.7M · quality 85.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
59/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$34M
P/E
12.5x
↓EV/EBITDA
10.3x
↓ROE
13.5%
↑Gross Margin
80.2%
↑Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
-1.4%
FCF CAGR
-3.5%
FCF margin
20.5%
FCF / Net income
1.15x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $12.4M · net income $2.2M · FCF $2.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $12.4M | $12.4M | $12.8M | $12.6M | $13.0M |
| Net Income | $2.2M | $2.2M | $2.8M | $1.0M | $1.7M |
| EBITDA | $3.0M | $3.0M | $3.6M | $1.8M | $2.9M |
| EPS | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Gross Margin | 80.2% | 80.2% | 77.5% | 76.9% | 73.1% |
| Operating Margin | 33.3% | 33.3% | 32.8% | 30.2% | 29.4% |
| Net Margin | 17.9% | 17.9% | 22.1% | 8.2% | 13.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.10 | 0.13 | 0.13 |
| Current Ratio | 3.50 | 3.50 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.5M | $2.5M | $3.3M | $2.7M | $2.8M |
| Returns | |||||
| ROE | 13.5% | 13.5% | 16.9% | 6.4% | 9.7% |
| Valuation | |||||
| P/E | 12.50 | 12.50 | 9.25 | 24.42 | 15.48 |
| EV/EBITDA | 10.28 | 10.28 | 6.81 | 13.53 | 8.68 |
| P/B | 2.02 | 2.02 | 1.57 | 1.57 | 1.50 |
| Growth & Yield | |||||
| Revenue Growth | -3.1% | -3.1% | 1.8% | -2.9% | — |
| EPS Growth | -22.0% | -22.0% | 177.9% | -38.9% | — |
| Dividend Yield | 6.7% | 6.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
9.9%
EPS terminal req.
$0.02
Spread vs growth
-31.9%
5Y implied EPS CAGR
10.0%
EPS terminal req.
$0.03
Spread vs growth
-31.9%
10Y implied EPS CAGR
10.0%
EPS terminal req.
$0.04
Spread vs growth
-31.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+31.7%
Start / end P/E
9.3x → 15.0x
EPS bridge
0.02 → 0.02
Residual
-13.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.